Description

RANIDOT-O combines the acid-suppressing power of Ranitidine, an H2 receptor antagonist, with Ondansetron, a selective 5-HT3 receptor antagonist that prevents nausea and vomiting. This dual-action tablet is ideal for conditions where hyperacidity and nausea coexist, such as gastritis, peptic ulcer disease, and gastrointestinal reflux disease (GERD), especially in post-operative or chemotherapy settings.

Key Benefits:

• Dual-action therapy for acidity and nausea

• Provides rapid relief from gastric discomfort

• Prevents vomiting in patients with GI disorders or under medical treatment

• Safe and effective in both hospital and outpatient care settings

Indications:

• Gastritis with nausea/vomiting

• GERD with emesis

• Post-operative nausea and vomiting

• Hyperacidity associated with nausea

• Drug-induced gastric irritation

Dosage & Administration:

To be taken as directed by a physician. Usually administered before meals or before exposure to emetogenic triggers.

Safety Information:

• Avoid in patients with known hypersensitivity to any component.

• Not recommended for long-term use without physician supervision.

• Use with caution in patients with renal or hepatic impairment.

Storage:

Store in a cool and dry place. Protect from light and moisture. Keep out of reach of children.

Packaging:

Each box contains 10 x 10 tablets.